Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk

Neurofibromatosis type 1 (NF1) predisposes individuals to the development of juvenile myelomonocytic leukemia (JMML), a fatal myeloproliferative disease (MPD). In genetically engineered murine models, nullizygosity of Nf1, a tumor suppressor gene that encodes a Ras-GTPase–activating protein, results...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Staser, Karl, Park, Su-Jung, Rhodes, Steven D., Zeng, Yi, He, Yong Zheng, Shew, Matthew A., Gehlhausen, Jeffrey R., Cerabona, Donna, Menon, Keshav, Chen, Shi, Sun, Zejin, Yuan, Jin, Ingram, David A., Nalepa, Grzegorz, Yang, Feng-Chun, Clapp, D. Wade
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Clinical Investigation 2012
Aiheet:
Brief Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3533306/
https://ncbi.nlm.nih.gov/pubmed/23221339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI66167
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia